Nabriva Therapeutics plc
NBRV
Ранг среди акций
#39893
Nabriva Therapeutics plc is a biopharmaceutical company focused on the... Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.
Цена акции
$0.63
Последняя синхронизация: 2023-08-29
Рыночная капитализация
$284.20K
Изменение (1 день)
-21.25%
Изменение (1 год)
629,900.02%
Страна
IE
Торговля Nabriva Therapeutics plc (NBRV)
Категория
Healthcare
Рыночная капитализация Nabriva Therapeutics plc(NBRV)
Рыночная капитализация: $284.20K
По состоянию на October 2026 рыночная капитализация Nabriva Therapeutics plc составляет $284.20K. Согласно нашим данным, Nabriva Therapeutics plc занимает 39893rd место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Nabriva Therapeutics plc с 2023 по 2026
NBRV по сравнению с пятеркой самых популярных stocks
| Цена за NBRV | Актив Б | Рыночная капитализация B | результаты | |
|---|---|---|---|---|
$1,626,116
$323.00
|
$5.252T | +1,626,115,789,373.68% | ||
|
$1,548,384
$323.00
|
$5.001T | +1,548,383,759,714.24% | ||
|
$1,292,928
$323.00
|
$4.176T | +1,292,927,561,393.19% | ||
|
$1,228,503
$323.00
|
$3.968T | +1,228,503,222,500.62% | ||
|
$878,360
$323.00
|
$2.837T | +878,360,467,252.94% |
